BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23697474)

  • 1. Primary nonadherence to statin medications in a managed care organization.
    Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
    J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System.
    Rashid N; Vassilakis M; Lin KJ; Kristy R; Ng DB
    J Manag Care Spec Pharm; 2017 Apr; 23(4):484-493. PubMed ID: 28345439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between statin adherence level, health care costs, and utilization.
    Zhao Y; Zabriski S; Bertram C
    J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.
    Evans CD; Eurich DT; Lamb DA; Taylor JG; Jorgenson DJ; Semchuk WM; Mansell KD; Blackburn DF
    J Manag Care Pharm; 2009; 15(6):476-84. PubMed ID: 19610680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK; Olsen CJ; Voelker J; Wander C
    J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonadherence to statin therapy: discontinuation after a single fill.
    Lemstra M; Blackburn D
    Can J Cardiol; 2012; 28(5):567-73. PubMed ID: 22658124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting.
    Stacy JN; Schwartz SM; Ershoff D; Shreve MS
    Popul Health Manag; 2009 Oct; 12(5):241-54. PubMed ID: 19848566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
    Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Adherence to Statin Medications of Patients Enrolled in a Self-insured University Health Plan.
    Range JT; LaFontaine PR; Ryder PT; Polston M
    Clin Ther; 2018 Oct; 40(10):1692-1700. PubMed ID: 30231972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users.
    Marcum ZA; Huang HC; Romanelli RJ
    J Gen Intern Med; 2019 Nov; 34(11):2559-2566. PubMed ID: 31367867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary non-adherence to bisphosphonates in an integrated healthcare setting.
    Reynolds K; Muntner P; Cheetham TC; Harrison TN; Morisky DE; Silverman S; Gold DT; Vansomphone SS; Wei R; O'Malley CD
    Osteoporos Int; 2013 Sep; 24(9):2509-17. PubMed ID: 23595561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Adherence Rates in Patients Utilizing a Patient-Centered Medical Home-Based Pharmacy.
    Slazak EM; Kozakiewicz JT; Winters NS; Smith JR; Monte SV
    J Pharm Pract; 2017 Oct; 30(5):516-520. PubMed ID: 27599748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization.
    Valuck RJ; Williams SA; MacArthur M; Saseen JJ; Nair KV; McCollum M; Ensor JE
    Clin Ther; 2003 Nov; 25(11):2936-57. PubMed ID: 14693317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
    Adamson AS; Suarez EA; Gorman AR
    JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
    Mitra D; Hodgkins P; Yen L; Davis KL; Cohen RD
    BMC Gastroenterol; 2012 Sep; 12():132. PubMed ID: 23006789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities.
    Halava H; Korhonen MJ; Huupponen R; Setoguchi S; Pentti J; Kivimäki M; Vahtera J
    CMAJ; 2014 Sep; 186(12):E449-56. PubMed ID: 24958839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.